Retraction: The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer (PLoS ONE (2020) 9:3 (e89841) DOI: 10.1371/journal.pone.0089841);The inhibitory effect of doxycycline on cisplatin-sensitive and -resistant epithelial ovarian cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wu, Wei ^a,b   Yu, Li Hua ^b   Ma, Bei ^b   Xu, Ming Juan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CISPLATIN; DOXYCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROCASPASE 3; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; CASPASE 3; CXCR4 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALIGNANT ASCITES; MOUSE; NONHUMAN; OVARY CARCINOMA; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DRUG EFFECTS; DRUG POTENTIATION; DRUG SCREENING; GENETICS; METABOLISM; NEOPLASMS, GLANDULAR AND EPITHELIAL; NUDE MOUSE; OVARIAN NEOPLASMS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; TUMOR CELL LINE; TUMOR INVASION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CXCL12; CISPLATIN; DOXYCYCLINE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION; HUMANS; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897148856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0231890     Document Type: Erratum

References (29)

1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277-300.
2. Bray F, Ren JS, Masuyer E, Ferlay J (2013) Global estimates of cancerprevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133-1145.
3. Suh DH, Kim K, Kim JW (2012) Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol 23:53-64.
4. Gubbels JA, Claussen N, Kapur AK, Connor JP, Patankar MS (2010) The detection, treatment, and biology of epithelial ovarian cancer. J Ovarian Res 3:8.
5. Bottone MG, Soldani C, Veneroni P, Avella D, Pisu M, et al. (2008) Cell proliferation, apoptosis and mitochondrial damage in rat B50 neuronal cells after cisplatin treatment. Cell Proliferation 41(3):506-520. (Pubitemid 351692946)
6. Marsh S (2009) Pharmacogenomics of Taxane/Platinum therapy in ovarian cancer. Int J Gynecol Cancer 2:30-34.
7. Jelovac D, Armstrong DK (2011) Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 61:183-203
8. Shen LC, Chen YK, Lin LM, Shaw SY (2010) Anti-invasion and anti-tumor growth effect of doxycycline treatment for human oral squamous-cell carcinoma-in vitro and in vivo studies. Oral Oncol 46(3):178-184.
9. Sun T, Zhao N, Ni CS, Zhao XL, Zhang WZ, et al (2009) Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK). Cancer Lett 28; 285(2):141-150.
10. Tang H, Sampath P, Yan X, Thorne SH (2013) Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination. Gene Ther doi: 10.1038/gt. 2012.96.
11. Han-jun L, Li-ya W, Hai-na Q, Li-hua Y, Burnstock G, et al (2011) P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Molecular and Cellular Endocrinology 338:28-37.
12. Barbieri E, Bajetto A, Florio T (2010) Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target. J Oncol 426956.
13. Balkwill F (2004) Cancer and the chemokine network. Net Rev Cancer 4:540-550.
14. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR (2001) Epithelial cancer cell migration: a role for chemokine receptor? Cancer Res 61:4961-4965. (Pubitemid 32681518)
15. Nonaka M, Itamochi H, Kawaguchi W, Kudoh A, Sato S, et al (2012) Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells. Int J Gynecol Cancer 22(6):922-929
16. Yoon H, Min JK, Lee JW, Kim DG, Hong HJ (2011) Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2. Biochem Biophys Res Commun 405(3):333-337.
17. Yang X, Zheng F, Xing H, Gao Q, Wei W, et al (2004) Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. J Cancer Res Clin Oncol 130:423-428. (Pubitemid 39044346)
18. Lai PB, Chi TY, Chen GG (2007) Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Apoptosis 12:387-393. (Pubitemid 46169918)
19. Mouratidis PX, Colston KW, Dalgleish AG (2007) Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells. Int J Cancer 120:743-752. (Pubitemid 46175392)
20. Onoda T, Ono T, Dhar DK, Yamanoi A, Nagasue N (2006) Tetracycline analogues (doxycyclinee and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells. Int J Cancer 118:1309-1315. (Pubitemid 43185622)
21. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, et al (2004) Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17-32. (Pubitemid 38903159)
22. Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, et al (2006) Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene 25:4986-4997.
23. Sato N, Matsubayashi H, Fukushima N Goggins M (2005) The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. Cancer Biol Ther 4:70-76. (Pubitemid 41350934)
24. Ueda Y, Neel NF, Schutyser E Raman D, Richmond A (2006) Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the downregulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Res 66:5665-5675. (Pubitemid 43927119)
25. Hay E (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233:706-720.
26. Miyanishi N, Suzuki Y, Simizu S, Kuwabara Y, Banno K, et al (2010) Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion. Biochem Biophys Res Commun 403:154-159.
27. Ganju RK, Brubaker SA, Meyer J Dutt P, Yang Y, et al (1998) The achemokine, stromal cell-derived factor-1a, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273:23169-23175. (Pubitemid 28417500)
28. Sotsios Y, Whittaker GC, Westwick J, Ward SG (1999) The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in Tlymphocytes. J Immunol 163:5954-5963.
29. Sun BC, Zhang SW, Qi LS, Zhang DF, Guo H, et al (2006) Study on the molecular mechanism of endostatin and doxycycline in suppressing melanoma growth. Zhonghua Bing Li Xue Za Zhi 35:677-680. (Pubitemid 46173572)